Basic info
Industry
biotechnology research
Sectors
cancer cell lysis
Biotechnology
oncolytic adenovirus
platform technology
biomedical engineering
cancer therapeutics
anti-metastatic
direct cancer cell lysis
senstizing cold tumor
antitumor immunity
genetic engineering
gene and cell therapy
anti neo-angioenesis
sysnergistic combination therapy
oncolytic virotherapy
Medical
drug delivery system
Date founded
2014
Funding rounds raised
Total raised
$15M
from 1 investors over 1 rounds
G
GeneMedicine raised $15M on May 1, 2019
Investors: IMM Investment Corp.